![Jennifer Ruff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer Ruff
Investor Relations Kontakt bei DIANTHUS THERAPEUTICS, INC.
Aktive Positionen von Jennifer Ruff
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Investor Relations Kontakt | 29.11.2023 | - |
Karriereverlauf von Jennifer Ruff
Ehemalige bekannte Positionen von Jennifer Ruff
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PYXIS ONCOLOGY, INC. | Investor Relations Kontakt | 01.01.2023 | 01.11.2023 |
TESARO INC | Investor Relations Kontakt | 01.03.2013 | 01.10.2018 |
Public Communications Contact | 01.03.2013 | 01.10.2018 | |
PFIZER, INC. | Investor Relations Kontakt | 01.06.2007 | 01.03.2013 |
MGI PHARMA Biologics, Inc.
![]() MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Public Communications Contact | 01.04.2003 | 01.05.2007 |
Ausbildung von Jennifer Ruff
Northwestern University | Graduate Degree |
University of Iowa | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Investor Relations Contact | 4 |
Public Communications Contact | 2 |
Graduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PYXIS ONCOLOGY, INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
MGI PHARMA Biologics, Inc.
![]() MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Tesaro, Inc.
![]() Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Jennifer Ruff
- Erfahrung